Google Translate Disclaimer

A number of pages on the Government of Saskatchewan`s web site have been professionally translated in French. These translations are identified by a yellow text box that resembles the link below and can be found in the right hand rail of the page. The home page for French-language content on this site can be found here:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

The results of software-based translation do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos, and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Saskatchewan To Fully Cover Mifegymiso

Released on June 7, 2019

Saskatchewan will provide 100 per cent coverage of Mifegymiso for residents eligible under the Saskatchewan Drug Plan, effective immediately.

Mifegymiso is the first oral product approved by Health Canada for medical termination of an early pregnancy.
Mifegymiso has been on the Saskatchewan Formulary and available by prescription since 2017, following a recommendation by Health Canada.  The cost of Mifegymiso to individual patients varied depending on their drug coverage and eligibility through benefit programs.  Now, full coverage brings Saskatchewan into line with other provinces and territories.

For more information, call the Drug Plan at 1-800-667-7581 toll-free or 306-787-3317 in Regina.

-30-

For more information, contact:

Shelley Svedahl
Health
Regina
Phone: 306-787-4083
Email: media@health.gov.sk.ca


We need your feedback to improve saskatchewan.ca. Help us improve